February 1, 2018
GlycoBiomarker Leading Innovation Co. Ltd.
Receipt of the 100th (2017) New Technology Development Grant
GL-i was selected for the grant for actualization of unique new technology by the New Technology Development Foundation with the theme of "Development of the system for safe and accurate assay of highly infectious viruses" (as of January 30, 2018).
|Supporting organization:||New Technology Development Foundation|
|Program title:||The 100th (2017) New Technology Development Grant|
|Project theme:||Development of the system for safe and accurate assay of highly infectious viruses|
|Project period:||February 13, 2018 to February 12, 2019|
|Project leader:||Hisashi Narimatsu (Fellow and Glycomedicine & Glycoinformatics Research Group)|
About the program (New Technology Development Foundation [Japanese])
Decision of the 100th (2017) New Technology Development Grant honorees ([Japanese])
GlycoBiomarker Leading Innovation Co. Ltd. (GL-i)
1-1-1 Umezono, Tsukuba, Ibaraki 305-8568 Japan
E-mail: firstname.lastname@example.org / URL: http://www.gl-i.co.jp/en/index_e.html